Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (271-280 of 433) with videos related to

Pageof 44
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trialsMing-Wen An, Sumithra J Mandrekar, Megan E Branda, et al.
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
Journal of the National Cancer Institute|October 15, 2011
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trialsGreg Yothers, Daniel J Sargent, Norman Wolmark, et al.
The New Phytologist|August 18, 2017
Altered regulation of TERMINAL FLOWER 1 causes the unique vernalisation response in an arctic woodland strawberry accessionElli A Koskela, Takeshi Kurokura, Tuomas Toivainen, et al.
Journal of the National Cancer Institute|November 9, 2014
DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147)Adam M Lee, Qian Shi, Emily Pavey, et al.
Cancer|March 3, 2011
Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! onlineSharlene Gill, Charles Loprinzi, Hagen Kennecke, et al.
Archives of Internal Medicine|October 1, 1990
Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesisS L Strongwater, B A Woda, R A Yood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data setMichael J O'Connell, Megan E Campbell, Richard M Goldberg, et al.
Infection and Immunity|December 23, 2003
The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activitiesL Garrity-Ryan, S Shafikhani, P Balachandran, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2015
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groupsXiaofei Wang, Lin Gu, Ying Zhang, et al.
Pageof 44

Showing results (271-280 of 433) with videos related to

Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2011
Comparison of continuous versus categorical tumor measurement-based metrics to predict overall survival in cancer treatment trialsMing-Wen An, Sumithra J Mandrekar, Megan E Branda, et al.
The New England Journal of Medicine|October 13, 2001
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patientsD J Sargent, R M Goldberg, S D Jacobson, et al.
Journal of the National Cancer Institute|October 15, 2011
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trialsGreg Yothers, Daniel J Sargent, Norman Wolmark, et al.
The New Phytologist|August 18, 2017
Altered regulation of TERMINAL FLOWER 1 causes the unique vernalisation response in an arctic woodland strawberry accessionElli A Koskela, Takeshi Kurokura, Tuomas Toivainen, et al.
Journal of the National Cancer Institute|November 9, 2014
DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147)Adam M Lee, Qian Shi, Emily Pavey, et al.
Cancer|March 3, 2011
Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! onlineSharlene Gill, Charles Loprinzi, Hagen Kennecke, et al.
Archives of Internal Medicine|October 1, 1990
Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesisS L Strongwater, B A Woda, R A Yood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data setMichael J O'Connell, Megan E Campbell, Richard M Goldberg, et al.
Infection and Immunity|December 23, 2003
The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activitiesL Garrity-Ryan, S Shafikhani, P Balachandran, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 2015
Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groupsXiaofei Wang, Lin Gu, Ying Zhang, et al.
Pageof 44